Mayinglong Pharmaceutical Group Co., Ltd.
600993
Rank in Stocks
#6365
Mayinglong Pharmaceutical Group Co., LTD. is a prominent Chinese entity... Mayinglong Pharmaceutical Group Co., LTD. is a prominent Chinese entity primarily engaged in the manufacturing, wholesale, and retail of a diverse array of pharmaceutical products. Its extensive offerings encompass treatments for hemorrhoid, gynecological, cough, and skin conditions, alongside functional foods, traditional Chinese medicine drink tablets, and various medical devices. The company also facilitates sales through online channels. Expanding its operations, it additionally manages and runs its own hospitals. Headquartered in Wuhan, China, Mayinglong Pharmaceutical Group Co., LTD. possesses a rich history, having been founded in 1582.
Share Price
$3.96
Last synced: 2026-11-19
Market Cap
$1.71B
Change (1 day)
1.75%
Change (1 year)
3.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Mayinglong Pharmaceutical Group Co., Ltd. (600993)
Category
Healthcare
EPS for Mayinglong Pharmaceutical Group Co., Ltd. (600993)
EPS as of September 2026 TTM: $0.21
According to Mayinglong Pharmaceutical Group Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.21. At the end of 2025 the company had an EPS of $0.19, an increase over its 2024 EPS of $0.17.
EPS history for Mayinglong Pharmaceutical Group Co., Ltd. from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.21 | 8.84% |
| 2025 | $0.19 | 14.54% |
| 2024 | $0.17 | 15.81% |
| 2023 | $0.15 | -9.57% |
| 2022 | $0.16 | -5.30% |
| 2021 | $0.17 | 14.41% |
| 2020 | $0.15 | 23.13% |
| 2019 | $0.12 | 102.35% |
| 2018 | $0.06 | -47.58% |
| 2017 | $0.11 | 36.17% |
| 2016 | $0.08 | 4.24% |
| 2015 | $0.08 | 5.53% |
| 2014 | $0.08 | 7.05% |
| 2013 | $0.07 | 10.61% |
| 2012 | $0.06 | 24.95% |
| 2011 | $0.05 | 19.03% |
| 2010 | $0.04 | -29.92% |
| 2009 | $0.06 | 121.22% |
| 2008 | $0.03 | -34.59% |
| 2007 | $0.04 | 97.67% |
| 2006 | $0.02 | 24.28% |
| 2005 | $0.02 | 1.76% |
| 2004 | $0.02 | 17.24% |
| 2003 | $0.01 | 59.34% |
| 2002 | $0.01 | 19.74% |
| 2001 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 2,815.81% |
DE
|
|
| $6.01 | 2,805.13% |
DE
|
|
| $1.53 | 641.25% |
JP
|
|
| $3.66 | 1,669.83% |
CH
|
|
| $0.45 | 117.60% |
IL
|
Questions about Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS)
What is Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS)?
Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.21, as of Sep 2026.
What was Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) was $0.19, 11.76% more than in 2024 ($0.17).
How has Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) went from $0.15 to $0.19, an average growth of 4.84% a year.
How does Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Mayinglong Pharmaceutical Group Co., Ltd.'s earnings per share (EPS) ($0.21) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.